Akshara Singareeka-Raghavendra

机构：The University of Texas MD Anderson Cancer Center

发表论文 2 篇 · 总被引 28 次 · h-index 1

代表论文

• Abstract PD4-02: Safety and efficacy of a tucatinib-trastuzumab-capecitabine regimen for treatment of leptomeningeal metastasis (LM) in HER2-positive breast cancer: Results from TBCRC049, a phase 2 non-randomized study (2022 · Cancer Research · 被引 27)
• Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results (2026 · Nature Cancer · 被引 1)